Utilization of the ketogenic diet for adults with status epilepticus

•Significant heterogeneity exists in the current practices employing ketogenic diet as treatment modality for status epilepticus.•Barriers identified for low rate of utilization of ketogenic diet for status epilepticus by healthcare providers include anticipated difficulty achieving ketosis, lack of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epilepsy & behavior 2023-07, Vol.144, p.109279-109279, Article 109279
Hauptverfasser: Teixeira, Fernanda J.P., Shannon, Jacqueline, Busl, Katharina M., Robinson, Christopher P., Ahmed, Bakhtawar, Katz, Jason, Miao, Guanhong, Seckar, Jenna, Bruzzone, Maria, Cervenka, Mackenzie C., Maciel, Carolina B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109279
container_issue
container_start_page 109279
container_title Epilepsy & behavior
container_volume 144
creator Teixeira, Fernanda J.P.
Shannon, Jacqueline
Busl, Katharina M.
Robinson, Christopher P.
Ahmed, Bakhtawar
Katz, Jason
Miao, Guanhong
Seckar, Jenna
Bruzzone, Maria
Cervenka, Mackenzie C.
Maciel, Carolina B.
description •Significant heterogeneity exists in the current practices employing ketogenic diet as treatment modality for status epilepticus.•Barriers identified for low rate of utilization of ketogenic diet for status epilepticus by healthcare providers include anticipated difficulty achieving ketosis, lack of expertise, lack of resources, and lack of dietitian support.•Randomized clinical trials supporting efficacy of ketogenic diet for status epilepticus could be instrumental in increased use of ketogenic diet by healthcare providers. The ketogenic diet (KD) is a high-fat, low-carbohydrate diet with therapeutic potential in refractory seizures, both in outpatient and inpatient settings. Successful implementation of KD involves a multifaceted, interdisciplinary approach to address anticipated challenges. We sought to characterize the utilization of KD among healthcare providers caring for adults with status epilepticus (SE). We distributed a web-based survey through professional societies, including the American Academy of Neurology (AAN), Neurocritical Care Society (NCS), American Epilepsy Society (AES), Neuro Anesthesia and Critical Care Society (NACCS), and the Academy of Nutrition and Dietetics (AND), and via research contacts. We asked respondents about practice experience and experience using KD as a treatment for SE. Descriptive statistics and Chi-square tests were used to analyze the results. Of 156 respondents, 80% of physicians and 18% of non-physicians reported experience with KD for SE. Anticipated difficulty in achieving ketosis (36.3%), lack of expertise (24.2%), and lack of resources (20.9%) were identified as the most important barriers limiting the utilization of KD. The absence of dietitians (37.1%) or pharmacists (25.7%) support was the most important missing resource. Reasons for stopping KD included perceived ineffectiveness (29.1%), difficulty achieving ketosis (24.6%), and side effects (17.3%). Academic centers had more experience with the use of KD and greater EEG monitoring availability and fewer barriers to its implementation. The need for randomized clinical trials supporting efficacy (36.5%) and better practice guidelines for implementation and maintenance of KD (29.6%) were cited most frequently as factors to increase utilization of KD. This study identifies important barriers to the utilization of KD as a treatment for SE despite evidence supporting its efficacy in the appropriate clinical context, namely lack of resources and interdisc
doi_str_mv 10.1016/j.yebeh.2023.109279
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2822709411</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525505023001981</els_id><sourcerecordid>2822709411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-57e14ac3c22429efecfc7016081f29db55973a043e8e03269b261c57de2fb2c93</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0EoqXwC5CQj1xS_IiT-MABladUiQs9W4mzpi5pHGwHVH49KS0cOe1qNTOr-RA6p2RKCc2uVtMNVLCcMsL4cJEslwdoTAUTiSCZPPzbBRmhkxBWhFAqOD1GI56zfMgoxuh2EW1jv8poXYudwXEJ-A2ie4XWalxbiNg4j8u6b2LAnzYucYhl7AOGzjbQRav7cIqOTNkEONvPCVrc373MHpP588PT7GaeaE5kTEQONC0114ylTIIBbXQ-NCEFNUzWlRAy5yVJORRAOMtkxTKqRV4DMxXTkk_Q5S638-69hxDV2gYNTVO24PqgWMFYTmRK6SDlO6n2LgQPRnXerku_UZSoLT61Uj_41Baf2uEbXBf7B321hvrP88trEFzvBDDU_LDgVdAWWg219aCjqp3998E3b9yBYQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2822709411</pqid></control><display><type>article</type><title>Utilization of the ketogenic diet for adults with status epilepticus</title><source>Access via ScienceDirect (Elsevier)</source><creator>Teixeira, Fernanda J.P. ; Shannon, Jacqueline ; Busl, Katharina M. ; Robinson, Christopher P. ; Ahmed, Bakhtawar ; Katz, Jason ; Miao, Guanhong ; Seckar, Jenna ; Bruzzone, Maria ; Cervenka, Mackenzie C. ; Maciel, Carolina B.</creator><creatorcontrib>Teixeira, Fernanda J.P. ; Shannon, Jacqueline ; Busl, Katharina M. ; Robinson, Christopher P. ; Ahmed, Bakhtawar ; Katz, Jason ; Miao, Guanhong ; Seckar, Jenna ; Bruzzone, Maria ; Cervenka, Mackenzie C. ; Maciel, Carolina B.</creatorcontrib><description>•Significant heterogeneity exists in the current practices employing ketogenic diet as treatment modality for status epilepticus.•Barriers identified for low rate of utilization of ketogenic diet for status epilepticus by healthcare providers include anticipated difficulty achieving ketosis, lack of expertise, lack of resources, and lack of dietitian support.•Randomized clinical trials supporting efficacy of ketogenic diet for status epilepticus could be instrumental in increased use of ketogenic diet by healthcare providers. The ketogenic diet (KD) is a high-fat, low-carbohydrate diet with therapeutic potential in refractory seizures, both in outpatient and inpatient settings. Successful implementation of KD involves a multifaceted, interdisciplinary approach to address anticipated challenges. We sought to characterize the utilization of KD among healthcare providers caring for adults with status epilepticus (SE). We distributed a web-based survey through professional societies, including the American Academy of Neurology (AAN), Neurocritical Care Society (NCS), American Epilepsy Society (AES), Neuro Anesthesia and Critical Care Society (NACCS), and the Academy of Nutrition and Dietetics (AND), and via research contacts. We asked respondents about practice experience and experience using KD as a treatment for SE. Descriptive statistics and Chi-square tests were used to analyze the results. Of 156 respondents, 80% of physicians and 18% of non-physicians reported experience with KD for SE. Anticipated difficulty in achieving ketosis (36.3%), lack of expertise (24.2%), and lack of resources (20.9%) were identified as the most important barriers limiting the utilization of KD. The absence of dietitians (37.1%) or pharmacists (25.7%) support was the most important missing resource. Reasons for stopping KD included perceived ineffectiveness (29.1%), difficulty achieving ketosis (24.6%), and side effects (17.3%). Academic centers had more experience with the use of KD and greater EEG monitoring availability and fewer barriers to its implementation. The need for randomized clinical trials supporting efficacy (36.5%) and better practice guidelines for implementation and maintenance of KD (29.6%) were cited most frequently as factors to increase utilization of KD. This study identifies important barriers to the utilization of KD as a treatment for SE despite evidence supporting its efficacy in the appropriate clinical context, namely lack of resources and interdisciplinary support, and lack of established practice guidelines. Our results highlight the need for future research to improve understanding of the efficacy and safety of KD along with better interdisciplinary collaborations to increase its utilization.</description><identifier>ISSN: 1525-5050</identifier><identifier>EISSN: 1525-5069</identifier><identifier>DOI: 10.1016/j.yebeh.2023.109279</identifier><identifier>PMID: 37271018</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Epilepsy ; Healthcare provider ; Ketoacidosis ; Ketogenic diet ; Ketosis ; Seizures ; Status epilepticus ; Survey</subject><ispartof>Epilepsy &amp; behavior, 2023-07, Vol.144, p.109279-109279, Article 109279</ispartof><rights>2023 Elsevier Inc.</rights><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-57e14ac3c22429efecfc7016081f29db55973a043e8e03269b261c57de2fb2c93</cites><orcidid>0000-0002-8763-5839 ; 0009-0001-3660-1487 ; 0000-0001-9961-0527 ; 0000-0002-4760-857X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.yebeh.2023.109279$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37271018$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teixeira, Fernanda J.P.</creatorcontrib><creatorcontrib>Shannon, Jacqueline</creatorcontrib><creatorcontrib>Busl, Katharina M.</creatorcontrib><creatorcontrib>Robinson, Christopher P.</creatorcontrib><creatorcontrib>Ahmed, Bakhtawar</creatorcontrib><creatorcontrib>Katz, Jason</creatorcontrib><creatorcontrib>Miao, Guanhong</creatorcontrib><creatorcontrib>Seckar, Jenna</creatorcontrib><creatorcontrib>Bruzzone, Maria</creatorcontrib><creatorcontrib>Cervenka, Mackenzie C.</creatorcontrib><creatorcontrib>Maciel, Carolina B.</creatorcontrib><title>Utilization of the ketogenic diet for adults with status epilepticus</title><title>Epilepsy &amp; behavior</title><addtitle>Epilepsy Behav</addtitle><description>•Significant heterogeneity exists in the current practices employing ketogenic diet as treatment modality for status epilepticus.•Barriers identified for low rate of utilization of ketogenic diet for status epilepticus by healthcare providers include anticipated difficulty achieving ketosis, lack of expertise, lack of resources, and lack of dietitian support.•Randomized clinical trials supporting efficacy of ketogenic diet for status epilepticus could be instrumental in increased use of ketogenic diet by healthcare providers. The ketogenic diet (KD) is a high-fat, low-carbohydrate diet with therapeutic potential in refractory seizures, both in outpatient and inpatient settings. Successful implementation of KD involves a multifaceted, interdisciplinary approach to address anticipated challenges. We sought to characterize the utilization of KD among healthcare providers caring for adults with status epilepticus (SE). We distributed a web-based survey through professional societies, including the American Academy of Neurology (AAN), Neurocritical Care Society (NCS), American Epilepsy Society (AES), Neuro Anesthesia and Critical Care Society (NACCS), and the Academy of Nutrition and Dietetics (AND), and via research contacts. We asked respondents about practice experience and experience using KD as a treatment for SE. Descriptive statistics and Chi-square tests were used to analyze the results. Of 156 respondents, 80% of physicians and 18% of non-physicians reported experience with KD for SE. Anticipated difficulty in achieving ketosis (36.3%), lack of expertise (24.2%), and lack of resources (20.9%) were identified as the most important barriers limiting the utilization of KD. The absence of dietitians (37.1%) or pharmacists (25.7%) support was the most important missing resource. Reasons for stopping KD included perceived ineffectiveness (29.1%), difficulty achieving ketosis (24.6%), and side effects (17.3%). Academic centers had more experience with the use of KD and greater EEG monitoring availability and fewer barriers to its implementation. The need for randomized clinical trials supporting efficacy (36.5%) and better practice guidelines for implementation and maintenance of KD (29.6%) were cited most frequently as factors to increase utilization of KD. This study identifies important barriers to the utilization of KD as a treatment for SE despite evidence supporting its efficacy in the appropriate clinical context, namely lack of resources and interdisciplinary support, and lack of established practice guidelines. Our results highlight the need for future research to improve understanding of the efficacy and safety of KD along with better interdisciplinary collaborations to increase its utilization.</description><subject>Epilepsy</subject><subject>Healthcare provider</subject><subject>Ketoacidosis</subject><subject>Ketogenic diet</subject><subject>Ketosis</subject><subject>Seizures</subject><subject>Status epilepticus</subject><subject>Survey</subject><issn>1525-5050</issn><issn>1525-5069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0EoqXwC5CQj1xS_IiT-MABladUiQs9W4mzpi5pHGwHVH49KS0cOe1qNTOr-RA6p2RKCc2uVtMNVLCcMsL4cJEslwdoTAUTiSCZPPzbBRmhkxBWhFAqOD1GI56zfMgoxuh2EW1jv8poXYudwXEJ-A2ie4XWalxbiNg4j8u6b2LAnzYucYhl7AOGzjbQRav7cIqOTNkEONvPCVrc373MHpP588PT7GaeaE5kTEQONC0114ylTIIBbXQ-NCEFNUzWlRAy5yVJORRAOMtkxTKqRV4DMxXTkk_Q5S638-69hxDV2gYNTVO24PqgWMFYTmRK6SDlO6n2LgQPRnXerku_UZSoLT61Uj_41Baf2uEbXBf7B321hvrP88trEFzvBDDU_LDgVdAWWg219aCjqp3998E3b9yBYQ</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Teixeira, Fernanda J.P.</creator><creator>Shannon, Jacqueline</creator><creator>Busl, Katharina M.</creator><creator>Robinson, Christopher P.</creator><creator>Ahmed, Bakhtawar</creator><creator>Katz, Jason</creator><creator>Miao, Guanhong</creator><creator>Seckar, Jenna</creator><creator>Bruzzone, Maria</creator><creator>Cervenka, Mackenzie C.</creator><creator>Maciel, Carolina B.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8763-5839</orcidid><orcidid>https://orcid.org/0009-0001-3660-1487</orcidid><orcidid>https://orcid.org/0000-0001-9961-0527</orcidid><orcidid>https://orcid.org/0000-0002-4760-857X</orcidid></search><sort><creationdate>202307</creationdate><title>Utilization of the ketogenic diet for adults with status epilepticus</title><author>Teixeira, Fernanda J.P. ; Shannon, Jacqueline ; Busl, Katharina M. ; Robinson, Christopher P. ; Ahmed, Bakhtawar ; Katz, Jason ; Miao, Guanhong ; Seckar, Jenna ; Bruzzone, Maria ; Cervenka, Mackenzie C. ; Maciel, Carolina B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-57e14ac3c22429efecfc7016081f29db55973a043e8e03269b261c57de2fb2c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Epilepsy</topic><topic>Healthcare provider</topic><topic>Ketoacidosis</topic><topic>Ketogenic diet</topic><topic>Ketosis</topic><topic>Seizures</topic><topic>Status epilepticus</topic><topic>Survey</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teixeira, Fernanda J.P.</creatorcontrib><creatorcontrib>Shannon, Jacqueline</creatorcontrib><creatorcontrib>Busl, Katharina M.</creatorcontrib><creatorcontrib>Robinson, Christopher P.</creatorcontrib><creatorcontrib>Ahmed, Bakhtawar</creatorcontrib><creatorcontrib>Katz, Jason</creatorcontrib><creatorcontrib>Miao, Guanhong</creatorcontrib><creatorcontrib>Seckar, Jenna</creatorcontrib><creatorcontrib>Bruzzone, Maria</creatorcontrib><creatorcontrib>Cervenka, Mackenzie C.</creatorcontrib><creatorcontrib>Maciel, Carolina B.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsy &amp; behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teixeira, Fernanda J.P.</au><au>Shannon, Jacqueline</au><au>Busl, Katharina M.</au><au>Robinson, Christopher P.</au><au>Ahmed, Bakhtawar</au><au>Katz, Jason</au><au>Miao, Guanhong</au><au>Seckar, Jenna</au><au>Bruzzone, Maria</au><au>Cervenka, Mackenzie C.</au><au>Maciel, Carolina B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utilization of the ketogenic diet for adults with status epilepticus</atitle><jtitle>Epilepsy &amp; behavior</jtitle><addtitle>Epilepsy Behav</addtitle><date>2023-07</date><risdate>2023</risdate><volume>144</volume><spage>109279</spage><epage>109279</epage><pages>109279-109279</pages><artnum>109279</artnum><issn>1525-5050</issn><eissn>1525-5069</eissn><abstract>•Significant heterogeneity exists in the current practices employing ketogenic diet as treatment modality for status epilepticus.•Barriers identified for low rate of utilization of ketogenic diet for status epilepticus by healthcare providers include anticipated difficulty achieving ketosis, lack of expertise, lack of resources, and lack of dietitian support.•Randomized clinical trials supporting efficacy of ketogenic diet for status epilepticus could be instrumental in increased use of ketogenic diet by healthcare providers. The ketogenic diet (KD) is a high-fat, low-carbohydrate diet with therapeutic potential in refractory seizures, both in outpatient and inpatient settings. Successful implementation of KD involves a multifaceted, interdisciplinary approach to address anticipated challenges. We sought to characterize the utilization of KD among healthcare providers caring for adults with status epilepticus (SE). We distributed a web-based survey through professional societies, including the American Academy of Neurology (AAN), Neurocritical Care Society (NCS), American Epilepsy Society (AES), Neuro Anesthesia and Critical Care Society (NACCS), and the Academy of Nutrition and Dietetics (AND), and via research contacts. We asked respondents about practice experience and experience using KD as a treatment for SE. Descriptive statistics and Chi-square tests were used to analyze the results. Of 156 respondents, 80% of physicians and 18% of non-physicians reported experience with KD for SE. Anticipated difficulty in achieving ketosis (36.3%), lack of expertise (24.2%), and lack of resources (20.9%) were identified as the most important barriers limiting the utilization of KD. The absence of dietitians (37.1%) or pharmacists (25.7%) support was the most important missing resource. Reasons for stopping KD included perceived ineffectiveness (29.1%), difficulty achieving ketosis (24.6%), and side effects (17.3%). Academic centers had more experience with the use of KD and greater EEG monitoring availability and fewer barriers to its implementation. The need for randomized clinical trials supporting efficacy (36.5%) and better practice guidelines for implementation and maintenance of KD (29.6%) were cited most frequently as factors to increase utilization of KD. This study identifies important barriers to the utilization of KD as a treatment for SE despite evidence supporting its efficacy in the appropriate clinical context, namely lack of resources and interdisciplinary support, and lack of established practice guidelines. Our results highlight the need for future research to improve understanding of the efficacy and safety of KD along with better interdisciplinary collaborations to increase its utilization.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37271018</pmid><doi>10.1016/j.yebeh.2023.109279</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-8763-5839</orcidid><orcidid>https://orcid.org/0009-0001-3660-1487</orcidid><orcidid>https://orcid.org/0000-0001-9961-0527</orcidid><orcidid>https://orcid.org/0000-0002-4760-857X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1525-5050
ispartof Epilepsy & behavior, 2023-07, Vol.144, p.109279-109279, Article 109279
issn 1525-5050
1525-5069
language eng
recordid cdi_proquest_miscellaneous_2822709411
source Access via ScienceDirect (Elsevier)
subjects Epilepsy
Healthcare provider
Ketoacidosis
Ketogenic diet
Ketosis
Seizures
Status epilepticus
Survey
title Utilization of the ketogenic diet for adults with status epilepticus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T06%3A32%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utilization%20of%20the%20ketogenic%20diet%20for%20adults%20with%20status%20epilepticus&rft.jtitle=Epilepsy%20&%20behavior&rft.au=Teixeira,%20Fernanda%20J.P.&rft.date=2023-07&rft.volume=144&rft.spage=109279&rft.epage=109279&rft.pages=109279-109279&rft.artnum=109279&rft.issn=1525-5050&rft.eissn=1525-5069&rft_id=info:doi/10.1016/j.yebeh.2023.109279&rft_dat=%3Cproquest_cross%3E2822709411%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2822709411&rft_id=info:pmid/37271018&rft_els_id=S1525505023001981&rfr_iscdi=true